IBDEI256 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,34208,1,3,0)
;;=3^Neuroleptic-Induced Parkinsonism
;;^UTILITY(U,$J,358.3,34208,1,4,0)
;;=4^G21.11
;;^UTILITY(U,$J,358.3,34208,2)
;;=^5003772
;;^UTILITY(U,$J,358.3,34209,0)
;;=G24.01^^134^1731^15
;;^UTILITY(U,$J,358.3,34209,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34209,1,3,0)
;;=3^Tardive Dyskinesia
;;^UTILITY(U,$J,358.3,34209,1,4,0)
;;=4^G24.01
;;^UTILITY(U,$J,358.3,34209,2)
;;=^5003784
;;^UTILITY(U,$J,358.3,34210,0)
;;=G24.09^^134^1731^16
;;^UTILITY(U,$J,358.3,34210,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34210,1,3,0)
;;=3^Tardive Dystonia
;;^UTILITY(U,$J,358.3,34210,1,4,0)
;;=4^G24.09
;;^UTILITY(U,$J,358.3,34210,2)
;;=^5003786
;;^UTILITY(U,$J,358.3,34211,0)
;;=G25.1^^134^1731^11
;;^UTILITY(U,$J,358.3,34211,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34211,1,3,0)
;;=3^Medication-Induced Postural Tremor
;;^UTILITY(U,$J,358.3,34211,1,4,0)
;;=4^G25.1
;;^UTILITY(U,$J,358.3,34211,2)
;;=^5003792
;;^UTILITY(U,$J,358.3,34212,0)
;;=G25.71^^134^1731^14
;;^UTILITY(U,$J,358.3,34212,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34212,1,3,0)
;;=3^Tardive Akathisia
;;^UTILITY(U,$J,358.3,34212,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,34212,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,34213,0)
;;=G25.79^^134^1731^9
;;^UTILITY(U,$J,358.3,34213,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34213,1,3,0)
;;=3^Medication-Induced Movement Disorder,Other
;;^UTILITY(U,$J,358.3,34213,1,4,0)
;;=4^G25.79
;;^UTILITY(U,$J,358.3,34213,2)
;;=^5003800
;;^UTILITY(U,$J,358.3,34214,0)
;;=T43.205A^^134^1731^4
;;^UTILITY(U,$J,358.3,34214,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34214,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
;;^UTILITY(U,$J,358.3,34214,1,4,0)
;;=4^T43.205A
;;^UTILITY(U,$J,358.3,34214,2)
;;=^5050540
;;^UTILITY(U,$J,358.3,34215,0)
;;=T43.205D^^134^1731^5
;;^UTILITY(U,$J,358.3,34215,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34215,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
;;^UTILITY(U,$J,358.3,34215,1,4,0)
;;=4^T43.205D
;;^UTILITY(U,$J,358.3,34215,2)
;;=^5050541
;;^UTILITY(U,$J,358.3,34216,0)
;;=T43.205S^^134^1731^6
;;^UTILITY(U,$J,358.3,34216,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34216,1,3,0)
;;=3^Antidepressant Discontinuation Syndrome,Sequela
;;^UTILITY(U,$J,358.3,34216,1,4,0)
;;=4^T43.205S
;;^UTILITY(U,$J,358.3,34216,2)
;;=^5050542
;;^UTILITY(U,$J,358.3,34217,0)
;;=G25.71^^134^1731^7
;;^UTILITY(U,$J,358.3,34217,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34217,1,3,0)
;;=3^Medication-Induced Acute Akathisia
;;^UTILITY(U,$J,358.3,34217,1,4,0)
;;=4^G25.71
;;^UTILITY(U,$J,358.3,34217,2)
;;=^5003799
;;^UTILITY(U,$J,358.3,34218,0)
;;=G24.02^^134^1731^8
;;^UTILITY(U,$J,358.3,34218,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34218,1,3,0)
;;=3^Medication-Induced Acute Dystonia
;;^UTILITY(U,$J,358.3,34218,1,4,0)
;;=4^G24.02
;;^UTILITY(U,$J,358.3,34218,2)
;;=^5003785
;;^UTILITY(U,$J,358.3,34219,0)
;;=G21.0^^134^1731^12
;;^UTILITY(U,$J,358.3,34219,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34219,1,3,0)
;;=3^Neuroleptic Malignant Syndrome
;;^UTILITY(U,$J,358.3,34219,1,4,0)
;;=4^G21.0
;;^UTILITY(U,$J,358.3,34219,2)
;;=^5003771
;;^UTILITY(U,$J,358.3,34220,0)
;;=T50.905A^^134^1731^1
;;^UTILITY(U,$J,358.3,34220,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34220,1,3,0)
;;=3^Adverse Effect of Medication,Other,Init Encntr
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI256 3817 printed Sep 23, 2025@19:58 Page 2
IBDEI256 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,34208,1,3,0)
+2 ;;=3^Neuroleptic-Induced Parkinsonism
+3 ;;^UTILITY(U,$J,358.3,34208,1,4,0)
+4 ;;=4^G21.11
+5 ;;^UTILITY(U,$J,358.3,34208,2)
+6 ;;=^5003772
+7 ;;^UTILITY(U,$J,358.3,34209,0)
+8 ;;=G24.01^^134^1731^15
+9 ;;^UTILITY(U,$J,358.3,34209,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,34209,1,3,0)
+12 ;;=3^Tardive Dyskinesia
+13 ;;^UTILITY(U,$J,358.3,34209,1,4,0)
+14 ;;=4^G24.01
+15 ;;^UTILITY(U,$J,358.3,34209,2)
+16 ;;=^5003784
+17 ;;^UTILITY(U,$J,358.3,34210,0)
+18 ;;=G24.09^^134^1731^16
+19 ;;^UTILITY(U,$J,358.3,34210,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,34210,1,3,0)
+22 ;;=3^Tardive Dystonia
+23 ;;^UTILITY(U,$J,358.3,34210,1,4,0)
+24 ;;=4^G24.09
+25 ;;^UTILITY(U,$J,358.3,34210,2)
+26 ;;=^5003786
+27 ;;^UTILITY(U,$J,358.3,34211,0)
+28 ;;=G25.1^^134^1731^11
+29 ;;^UTILITY(U,$J,358.3,34211,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,34211,1,3,0)
+32 ;;=3^Medication-Induced Postural Tremor
+33 ;;^UTILITY(U,$J,358.3,34211,1,4,0)
+34 ;;=4^G25.1
+35 ;;^UTILITY(U,$J,358.3,34211,2)
+36 ;;=^5003792
+37 ;;^UTILITY(U,$J,358.3,34212,0)
+38 ;;=G25.71^^134^1731^14
+39 ;;^UTILITY(U,$J,358.3,34212,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,34212,1,3,0)
+42 ;;=3^Tardive Akathisia
+43 ;;^UTILITY(U,$J,358.3,34212,1,4,0)
+44 ;;=4^G25.71
+45 ;;^UTILITY(U,$J,358.3,34212,2)
+46 ;;=^5003799
+47 ;;^UTILITY(U,$J,358.3,34213,0)
+48 ;;=G25.79^^134^1731^9
+49 ;;^UTILITY(U,$J,358.3,34213,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,34213,1,3,0)
+52 ;;=3^Medication-Induced Movement Disorder,Other
+53 ;;^UTILITY(U,$J,358.3,34213,1,4,0)
+54 ;;=4^G25.79
+55 ;;^UTILITY(U,$J,358.3,34213,2)
+56 ;;=^5003800
+57 ;;^UTILITY(U,$J,358.3,34214,0)
+58 ;;=T43.205A^^134^1731^4
+59 ;;^UTILITY(U,$J,358.3,34214,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,34214,1,3,0)
+62 ;;=3^Antidepressant Discontinuation Syndrome,Init Encntr
+63 ;;^UTILITY(U,$J,358.3,34214,1,4,0)
+64 ;;=4^T43.205A
+65 ;;^UTILITY(U,$J,358.3,34214,2)
+66 ;;=^5050540
+67 ;;^UTILITY(U,$J,358.3,34215,0)
+68 ;;=T43.205D^^134^1731^5
+69 ;;^UTILITY(U,$J,358.3,34215,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,34215,1,3,0)
+72 ;;=3^Antidepressant Discontinuation Syndrome,Subseq Encntr
+73 ;;^UTILITY(U,$J,358.3,34215,1,4,0)
+74 ;;=4^T43.205D
+75 ;;^UTILITY(U,$J,358.3,34215,2)
+76 ;;=^5050541
+77 ;;^UTILITY(U,$J,358.3,34216,0)
+78 ;;=T43.205S^^134^1731^6
+79 ;;^UTILITY(U,$J,358.3,34216,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,34216,1,3,0)
+82 ;;=3^Antidepressant Discontinuation Syndrome,Sequela
+83 ;;^UTILITY(U,$J,358.3,34216,1,4,0)
+84 ;;=4^T43.205S
+85 ;;^UTILITY(U,$J,358.3,34216,2)
+86 ;;=^5050542
+87 ;;^UTILITY(U,$J,358.3,34217,0)
+88 ;;=G25.71^^134^1731^7
+89 ;;^UTILITY(U,$J,358.3,34217,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,34217,1,3,0)
+92 ;;=3^Medication-Induced Acute Akathisia
+93 ;;^UTILITY(U,$J,358.3,34217,1,4,0)
+94 ;;=4^G25.71
+95 ;;^UTILITY(U,$J,358.3,34217,2)
+96 ;;=^5003799
+97 ;;^UTILITY(U,$J,358.3,34218,0)
+98 ;;=G24.02^^134^1731^8
+99 ;;^UTILITY(U,$J,358.3,34218,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,34218,1,3,0)
+102 ;;=3^Medication-Induced Acute Dystonia
+103 ;;^UTILITY(U,$J,358.3,34218,1,4,0)
+104 ;;=4^G24.02
+105 ;;^UTILITY(U,$J,358.3,34218,2)
+106 ;;=^5003785
+107 ;;^UTILITY(U,$J,358.3,34219,0)
+108 ;;=G21.0^^134^1731^12
+109 ;;^UTILITY(U,$J,358.3,34219,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,34219,1,3,0)
+112 ;;=3^Neuroleptic Malignant Syndrome
+113 ;;^UTILITY(U,$J,358.3,34219,1,4,0)
+114 ;;=4^G21.0
+115 ;;^UTILITY(U,$J,358.3,34219,2)
+116 ;;=^5003771
+117 ;;^UTILITY(U,$J,358.3,34220,0)
+118 ;;=T50.905A^^134^1731^1
+119 ;;^UTILITY(U,$J,358.3,34220,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,34220,1,3,0)
+122 ;;=3^Adverse Effect of Medication,Other,Init Encntr
